CYP19A1 and breast carcinoma: LBH589 (panobinostat) is a histone deacetylase inhibitor that has been previously shown to suppress the proliferation of aromatase inhibitor resistant breast cancer cells, which was a conclusion supported in part by functional enrichment analysis of commonly affected genes from 3 cell line experiments (Kubo et al., 2013).